Symvivo Corporation

About:

Symvivo Corporation is a clinical-stage biotechnology company that develops DNA vaccines for genetic and life-threatening diseases.

Website: https://www.symvivo.com/about

Top Investors: Pacific Economic Development Canada

Description:

Symvivo Corporation is a platform that delivers plasmid DNA, both orally and through IV administration, that enables a patient’s own cells to produce biologics. They make therapeutic developments in the fields of oral vaccines, cancer, immunology, and biologics. Symvivo Corporation is creating the next generation of vaccines by offering orally delivered, room-temperature stable medicines that can generate both systemic and mucosal immunity, as well as scalable and cost-effective manufacturing procedures.